Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 304Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 3AbbVie Inc

02 1Zeon Pharma Industries India Pvt Ltd

03 3ANDA Repository

04 3Alkem Laboratories

05 3Associated Biotech

06 2Astellas Pharma

07 3Aurobindo Pharma Limited

08 3Chartwell Pharmaceuticals llc

09 5DEVATS INDIA

10 1Jodas Expoim Pvt. Ltd

11 3Lupin Ltd

12 2Nectar Lifesciences

13 4Nobel Ilac Sanayii Ve Ticaret A.S.

14 3Orchid Pharma

15 3Teva Pharmaceutical Industries

16 3Unosource Pharma

17 2Utopia

18 6World Medicine

19 2XL Laboratories Private Limited

20 2Zim Laboratories

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

CEFDINIR

Brand Name : OMNICEF

Dosage Form : CAPSULE;ORAL

Dosage Strength : 300MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Packaging :

Approval Date : 1997-12-04

Application Number : 50739

Regulatory Info : DISCN

Registration Country : USA

Abbvie Company Banner

02

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothZeon Pharma is a manufacturer and supplier of APIs & Intermediates.

Regulatory Info :

Registration Country : India

Cefdinir

Brand Name : Cefdinir

Dosage Form : DC Granules

Dosage Strength :

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

Zeon Pharma Industries India Pvt Ltd

03

CEFDINIR

Brand Name : OMNICEF

Dosage Form : FOR SUSPENSION;ORAL

Dosage Strength : 125MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Packaging :

Approval Date : 1997-12-04

Application Number : 50749

Regulatory Info : DISCN

Registration Country : USA

Abbvie Company Banner

04

CEFDINIR

Brand Name : OMNICEF

Dosage Form : FOR SUSPENSION;ORAL

Dosage Strength : 250MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Packaging :

Approval Date : 2004-07-29

Application Number : 50749

Regulatory Info : DISCN

Registration Country : USA

Abbvie Company Banner

05

ISPE Annual Meeting
Not Confirmed
arrow
arrow
ISPE Annual Meeting
Not Confirmed

CEFDINIR

Brand Name : CEFDINIR

Dosage Form : CAPSULE;ORAL

Dosage Strength : 300MG

Packaging :

Approval Date : 2021-02-19

Application Number : 210220

Regulatory Info : RX

Registration Country : USA

blank

06

ISPE Annual Meeting
Not Confirmed
arrow
arrow
ISPE Annual Meeting
Not Confirmed

CEFDINIR

Brand Name : CEFDINIR

Dosage Form : CAPSULE;ORAL

Dosage Strength : 300MG

Packaging :

Approval Date : 2007-07-18

Application Number : 65418

Regulatory Info : RX

Registration Country : USA

blank

07

ISPE Annual Meeting
Not Confirmed
arrow
arrow
ISPE Annual Meeting
Not Confirmed

CEFDINIR

Brand Name : CEFDINIR

Dosage Form : FOR SUSPENSION;ORAL

Dosage Strength : 125MG/5ML

Packaging :

Approval Date : 2007-07-18

Application Number : 65429

Regulatory Info : RX

Registration Country : USA

blank

08

ISPE Annual Meeting
Not Confirmed
arrow
arrow
ISPE Annual Meeting
Not Confirmed

CEFDINIR

Brand Name : CEFDINIR

Dosage Form : FOR SUSPENSION;ORAL

Dosage Strength : 250MG/5ML

Packaging :

Approval Date : 2007-07-18

Application Number : 65429

Regulatory Info : RX

Registration Country : USA

blank

09

ISPE Annual Meeting
Not Confirmed
arrow
arrow
ISPE Annual Meeting
Not Confirmed

CEFDINIR

Brand Name : CEFDINIR

Dosage Form : CAPSULE;ORAL

Dosage Strength : 300MG

Packaging :

Approval Date : 2008-01-07

Application Number : 65434

Regulatory Info : RX

Registration Country : USA

blank

10

ISPE Annual Meeting
Not Confirmed
arrow
arrow
ISPE Annual Meeting
Not Confirmed

CEFDINIR

Brand Name : CEFDINIR

Dosage Form : FOR SUSPENSION;ORAL

Dosage Strength : 125MG/5ML

Packaging :

Approval Date : 2007-12-14

Application Number : 65473

Regulatory Info : RX

Registration Country : USA

blank

11

ISPE Annual Meeting
Not Confirmed
arrow
arrow
ISPE Annual Meeting
Not Confirmed

CEFDINIR

Brand Name : CEFDINIR

Dosage Form : FOR SUSPENSION;ORAL

Dosage Strength : 250MG/5ML

Packaging :

Approval Date : 2007-12-14

Application Number : 65473

Regulatory Info : RX

Registration Country : USA

blank

12

ISPE Annual Meeting
Not Confirmed
arrow
arrow
ISPE Annual Meeting
Not Confirmed

CEFDINIR

Brand Name : CEFDINIR

Dosage Form : CAPSULE;ORAL

Dosage Strength : 300MG

Packaging :

Approval Date : 2007-04-06

Application Number : 65330

Regulatory Info : RX

Registration Country : USA

blank

13

ISPE Annual Meeting
Not Confirmed
arrow
arrow
ISPE Annual Meeting
Not Confirmed

CEFDINIR

Brand Name : CEFDINIR

Dosage Form : FOR SUSPENSION;ORAL

Dosage Strength : 125MG/5ML

Packaging :

Approval Date : 2007-04-06

Application Number : 65337

Regulatory Info : RX

Registration Country : USA

blank

14

ISPE Annual Meeting
Not Confirmed
arrow
arrow
ISPE Annual Meeting
Not Confirmed

CEFDINIR

Brand Name : CEFDINIR

Dosage Form : FOR SUSPENSION;ORAL

Dosage Strength : 250MG/5ML

Packaging :

Approval Date : 2007-04-06

Application Number : 65337

Regulatory Info : RX

Registration Country : USA

blank

15

ISPE Annual Meeting
Not Confirmed
arrow
arrow
ISPE Annual Meeting
Not Confirmed

CEFDINIR

Brand Name : CEFDINIR

Dosage Form : FOR SUSPENSION;ORAL

Dosage Strength : 125MG/5ML

Packaging :

Approval Date : 2006-05-31

Application Number : 65259

Regulatory Info : RX

Registration Country : USA

blank

16

ISPE Annual Meeting
Not Confirmed
arrow
arrow
ISPE Annual Meeting
Not Confirmed

CEFDINIR

Brand Name : CEFDINIR

Dosage Form : FOR SUSPENSION;ORAL

Dosage Strength : 250MG/5ML

Packaging :

Approval Date : 2007-05-07

Application Number : 65259

Regulatory Info : RX

Registration Country : USA

blank

17

ISPE Annual Meeting
Not Confirmed
arrow
arrow
ISPE Annual Meeting
Not Confirmed

CEFDINIR

Brand Name : CEFDINIR

Dosage Form : CAPSULE;ORAL

Dosage Strength : 300MG

Packaging :

Approval Date : 2006-05-19

Application Number : 65264

Regulatory Info : RX

Registration Country : USA

blank

18

ISPE Annual Meeting
Not Confirmed
arrow
arrow
ISPE Annual Meeting
Not Confirmed

CEFDINIR

Brand Name : CEFDINIR

Dosage Form : FOR SUSPENSION;ORAL

Dosage Strength : 125MG/5ML

Packaging :

Approval Date : 2007-05-04

Application Number : 65332

Regulatory Info : RX

Registration Country : USA

blank

19

ISPE Annual Meeting
Not Confirmed
arrow
arrow
ISPE Annual Meeting
Not Confirmed

CEFDINIR

Brand Name : CEFDINIR

Dosage Form : FOR SUSPENSION;ORAL

Dosage Strength : 250MG/5ML

Packaging :

Approval Date : 2007-05-04

Application Number : 65332

Regulatory Info : RX

Registration Country : USA

blank

20

ISPE Annual Meeting
Not Confirmed
arrow
arrow
ISPE Annual Meeting
Not Confirmed

CEFDINIR

Brand Name : CEFDINIR

Dosage Form : CAPSULE;ORAL

Dosage Strength : 300MG

Packaging :

Approval Date : 2007-05-09

Application Number : 65368

Regulatory Info : RX

Registration Country : USA

blank